AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 77, Issue 7 846-848, Copyright © 1987 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abrams, D B
Right arrow Articles by Hitti, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abrams, D B
Right arrow Articles by Hitti, J
Saliva cotinine as a measure of smoking status in field settings.

D B Abrams, M J Follick, L Biener, K B Carey and J Hitti

The accuracy and reliability of saliva cotinine as an objective measure of smoking status was examined in two field studies. In Study I, saliva was collected from smokers and nonsmokers with repeated samples taken from a randomly selected subset of the smokers. Results indicated perfect classification of smokers versus nonsmokers and acceptable reliability of repeated samples. Study II investigated the accuracy of saliva cotinine in detecting recent quitters in a worksite smoking cessation program. Saliva cotinine showed greater accuracy than expired carbon monoxide at detecting quitters, provided they were abstinent for at least seven days. From pre- to post-treatment, subject's saliva cotinine levels dropped 19 per cent while self-reported rate of smoking dropped 54 per cent. Saliva collection in the field is feasible and cotinine appears to be one of the more sensitive assays currently available for epidemiologic and clinical applications.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. H. Lubin, N. Caporaso, D. K. Hatsukami, A. M. Joseph, and S. S. Hecht
The Association of a Tobacco-Specific Biomarker and Cigarette Consumption and Its Dependence on Host Characteristics
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1852 - 1857.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
V. Malaiyandi, S. D. Goodz, E. M. Sellers, and R. F. Tyndale
CYP2A6 Genotype, Phenotype, and the Use of Nicotine Metabolites as Biomarkers during Ad libitum Smoking.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1812 - 1819.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. L. Studts, S. R. Ghate, J. L. Gill, C. R. Studts, C. N. Barnes, A. S. LaJoie, M. A. Andrykowski, and R. V. LaRocca
Validity of Self-reported Smoking Status among Participants in a Lung Cancer Screening Trial.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1825 - 1828.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
C. J. Ogborn, A. K. Duggan, and C. DeAngelis
Urinary Cotinine as a Measure of Passive Smoke Exposure in Asthmatic Children
Clinical Pediatrics, April 1, 1994; 33(4): 220 - 226.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Public Health Association